Acute lung injury and the coagulation pathway: Potential role of gene polymorphisms in the protein C and fibrinolytic pathways

Intensive Care Medicine

Volumn 32, Issue 9, 2006, Pages 1293-1303

  Sapru, Anil ^a   Wiemels, Joseph L ^b   Witte, John S ^b   Ware, Lorraine B ^c   Matthay, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN C;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD CLOTTING; DISEASE PREDISPOSITION; DISEASE SEVERITY; FIBRINOLYSIS; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; HEREDITY; HUMAN; MOLECULAR CLONING; PHENOTYPE; PROTEIN BLOOD LEVEL;

BLOOD COAGULATION; FIBRINOLYSIS; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN C; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 33747604588     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-006-0223-5     Document Type: Article

References (82)

1. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, Leppert M, Matalon S, Munford R, Parsons P, Slutsky AS, Tracey KJ, Ward P, Gail DB, Harabin AL (2003) Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 167:1027-1035
2. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD (2005) Incidence and outcomes of acute lung injury. N Engl J Med 353:1685-1693
3. Brun-Buisson C,Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, Bion J, Romand JA, Villar J, Thorsteinsson A, Damas P, Armaganidis A, Lemaire F (2004) Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 30:51-61
4. Flori HR, Glidden DV, Rutherford GW, Matthay MA (2005) Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med 171:995-1001
5. Villar J (2002) Genetics and the pathogenesis of adult respiratory distress syndrome. Curr Opin Crit Care 8:1-5
6. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258-264
7. Paparella D, Brister SJ, Buchanan MR (2004) Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 30:1873-1881
8. Amaral A, Opal SM, Vincent JL (2004) Coagulation in sepsis. Intensive Care Med 30:1032-1040
9. Idell S (2002) Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways. Crit Care Med 30:S274-280
10. Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, Chapman HA Jr (1990) Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322:890-897
11. Su X, Camerer E, Hamilton JR, Coughlin SR, Matthay MA (2005) Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms. J Immunol 175:2598-2605
12. Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, Garrard CS, van der Poll T (2004) Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 59:130-135
13. Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, Seeger W (2000) Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 161:454-462
14. Vadasz I, Morty RE, Olschewski A, Konigshoff M, Kohstall MG, Ghofrani HA, Grimminger F, Seeger W (2005) Thrombin impairs alveolar fluid clearance by promoting endocytosis of Na+,K+-ATPase. Am J Respir Cell Mol Biol 33:343-354
15. Nuckton TJ, Alonso JA, Kallet RH, Daniel BM, Pittet JF, Eisner MD, Matthay MA (2002) Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 346:1281-1286
16. Prudhomme J.B, Wang L, Wickersham N, Matthay M.A, Ware L.B (2005) Tissue factor levels in ARDS are 100-fold higher in edema fluid compared to plasma and correlate with mortality. Proc Am Thoracic Soc 2:A826
17. Van de Wouwer M, Collen D, Conway EM (2004) Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol 24:1374-1383
18. Sturn DH, Kaneider NC, Feistritzer C, Djanani A, Fukudome K, Wiedermann CJ (2003) Expression and function of the endothelial protein C receptor in human neutrophils. Blood 102:1499-1505
19. Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K, Richter D, Kast KR, Abraham E (2004) Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104:3878-3885
20. Ware LB, Fang X, Matthay MA (2003) Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol 285:L514-521
21. Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA (2003) Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 285:L20-28
22. Ware LB, Eisner M, Wickersham N, Olman MA, Thompson B, Parsons P, Matthay MA (2004) Plasminogen activator inhibitor-1 (PAI-1), a marker of impaired fibrinolysis, is associated with higher mortality in patients with ALI/ARDS. Am J Respir Crit Care Med 169:A115
23. Ware LB, Ancukiewicz M, Parsons PI, Matthay MA (2003) Prognostic value of plasma protein C in patients with acute lung injury. Am J Respir CritCare Med 167:A661
24. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ (1982) Clinical predictors of the adult respiratory distress syndrome. Am J Surg 144:124-130
25. Hudson LD, Milberg JA, Anardi D, Maunder RJ (1995) Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151:293-301
26. Kleeberger SR, Reddy S, Zhang LY, Jedlicka AE (2000) Genetic susceptibility to ozone-induced lung hyperpermeability: role of toll-like receptor 4. Am J Respir Cell Mol Biol 22:620-627
27. Leikauf GD, McDowell SA, Wesselkamper SC, Hardie WD, Leikauf JE, Korfhagen TR, Prows DR (2002) Acute lung injury: functional genomics and genetic susceptibility. Chest 121:70S-75S
28. Grigoryev DN, Finigan JH, Hassoun P, Garcia JG (2004) Science review: searching for gene candidates in acute lung injury. Crit Care 8:440-447
29. Currier PF GM, Pothier LJ, Boyce PD, Thompson BT, Christiani DC (2005) Surfactant protein-B polymorphism is associated with increased mortality at 28 days in ARDS patients. Proc Am Thoracic Soc 2:A243
30. Wattanathum A, Manocha S, Groshaus H, Russell JA, Walley KR (2005) Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest 128:1690-1698
31. Gao L, Grant A, Halder I, Brower R, Sevransky J, Maloney JP, Moss M, Shanholtz C, Yates CR, Umberto Meduri G, Shriver MD, Ingersoll R, Scott AF, Beaty TH, Moitra J, Ma SF, Ye SQ, Barnes KC, Garcia JG (2006) Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 1044-1549
32. Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, Fujita T, Nukiwa T (2004) Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest 126:95-99
33. Gong MN, Wei Z, Xu LL, Miller DP, Thompson BT, Christiani DC (2004) Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest 125:203-211
34. Gong MN, Zhou W, Williams PL, Thompson BT, Pothier L, Boyce P, Christiani DC (2005) -308GA and TNFB polymorphisms in acute respiratory distress syndrome. Eur Respir J 26:382-389
35. Gong MN ZW, Pothier L, Thompson BT, Christiani DC (2005) Mannose-binding lectin polymorphisms and ARDS. Proc Am Thoracic Soc 2:A243
36. Lin Z, Pearson C, Chinchilli V, Pietschmann SM, Luo J, Pison U, Floros J (2000) Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 58:181-191
37. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ (2002) Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 166:646-650
38. Medford AR, Keen LJ, Bidwell JL, Millar AB (2005) Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome. Thorax 60:244-248
39. Quasney MW, Waterer GW, Dahmer MK, Kron GK, Zhang Q, Kessler LA, Wunderink RG (2004) Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia. Crit Care Med 32:1115-1119
40. Ye SQ, Simon BA, Maloney JP, Zambelli-Weiner A, Gao L, Grant A, Easley RB, McVerry BJ, Tuder RM, Standiford T, Brower RG, Barnes KC, Garcia JG (2005) Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 171:361-370
41. Wunderink RG, Waterer GW, Cantor RM, Quasney MW (2002) Tumor necrosis factor gene polymorphisms and the variable presentation and outcome of community-acquired pneumonia. Chest 121:87S
42. Russell JA (2003) Genetics of coagulation factors in acute lung injury. Crit Care Med 31:S243-247
43. Rebbeck TR, Spitz M, Wu X (2004) Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet 5:589-597
44. Aiach M, Nicaud V, Alhenc-Gelas M, Gandrille S, Arnaud E, Amiral J, Guize L, Fiessinger JN, Emmerich J (1999) Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol 19:1573-1576
45. Arnaud E, Barbalat V, Nicaud V, Cambien F, Evans A, Morrison C, Arveiler D, Luc G, Ruidavets JB, Emmerich J, Fiessinger JN, Aiach M (2000) Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Temoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study. Arterioscler Thromb Vasc Biol 20:892-898
46. Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M (1999) 4G/5G promoter polymorphism in the plasminogen-activator- inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 354:556-560
47. Hoekstra T, Geleijnse JM, Schouten EG, Kluft C (2004) Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk. Thromb Haemost 91:861-872
48. Norlund L, Holm J, Zoller B, Ohlin AK (1997) A common thrombomodulin amino acid dimorphism is associated with myocardial infarction. Thromb Haemost 77:248-251
49. Saposnik B, Reny JL, Gaussem P, Emmerich J, Aiach M, Gandrille S (2004) A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood 103:1311-1318
50. Uitte de Willige S, Van Marion V, Rosendaal FR, Vos HL, de Visser MC, Bertina RM (2004) Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost 2:1305-1310
51. Endler G, Mannhalter C (2003) Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta 330:31-55
52. Kottke-Marchant K (2002) Genetic polymorphisms associated with venous and arterial thrombosis: an overview. Arch Pathol Lab Med 126:295-304
53. Lane DA, Grant PJ (2000) Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95:1517-1532
54. Eriksson P, Kallin B, van 't Hooft FM, Bavenholm P, Hamsten A (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 92:1851-1855
55. Henry M, Tregouet DA, Alessi MC, Aillaud MF, Visvikis S, Siest G, Tiret L, Juhan-Vague I (1998) Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. Arterioscler Thromb Vasc Biol 18:84-91
56. McCormack LJ, Semple JI, Stickland MH, Barrett JH, Grant PJ (1998) The effect of number of days in culture and plasminogen activator inhibitor-1 (PAI-1) 4G/5G genotype on PAI-1 antigen release by cultured human umbilical vein endothelial cells. Thromb Res 92:199-206
57. Barnes KC (2005) Genetic determinants and ethnic disparities in sepsis-associated acute lung injury. Proc Am Thorac Soc 2:195-201
58. Khadaroo RG, Marshall JC (2002) ARDS and the multiple organ dysfunction syndrome. Common mechanisms of a common systemic process. Crit Care Clin 18:127-141
59. Rubenfeld GD, Christie JD (2004) The epidemiologist in the intensive care unit. Intensive Care Med 30:4-6
60. Cardon LR, Bell JI (2001) Association study designs for complex diseases. Nat Rev Genet 2:91-99
61. Risch NJ (2000) Searching for genetic determinants in the new millennium. Nature 405:847-856
62. Romero R, Kuivaniemi H, Tromp G, Olson J (2002) The design, execution, and interpretation of genetic association studies to decipher complex diseases. Am J Obstet Gynecol 187:1299-1312
63. Lander ES (1996) The new genomics: global views of biology. Science 274:536-539
64. Browner W (2001) Estimating sample size. In Browner W, Newman T, Cummings S, Hulley S (eds) Designing clinical research: an epidemiologic approach. Lippincott Williams & Wilkins, Philadelphia, p 75
65. Newton-Cheh C, Hirschhorn JN (2005) Genetic association studies of complex traits: design and analysis issues. Mutat Res 573:54-69
66. Lyon H, Lange C, Lake S, Silverman EK, Randolph AG, Kwiatkowski D, Raby BA, Lazarus R, Weiland KM, Laird N, Weiss ST (2004) IL10 gene polymorphisms are associated with asthma phenotypes in children. Genet Epidemiol 26:155-165
67. Ozturk A, Dekosky ST, Kamboh MI (2005) Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease. Neurobiol Aging DOI: 10.10.16/j.neurobiolaging.2005.08.02.4
68. Prince JA, Feuk L, Gu HF, Johansson B, Gatz M, Blennow K, Brookes AJ (2003) Genetic variation in a haplotype block spanning IDE influences Alzheimer disease. Hum Mutat 22:363-371
69. Wanic K, Malecki MT, Wolkow PP, Klupa T, Skupien J, Bobrek J, Kozek E, Krolewski AS, Sieradzki J (2006) Polymorphisms in the gene encoding hepatocyte nuclear factor-4alpha and susceptibility to type 2 diabetes in a Polish population. Diabetes Metab 32:86-88
70. Mattevi VS, Zembrzuski VM, Hutz MH (2006) Impact of variation in ADRB2, ADRB3, and GNB3 genes on body mass index and waist circumference in a Brazilian population. Am J Hum Biol 18:182-186
71. Silverman EK, Palmer LJ (2000) Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol 22:645-648
72. Morrison J, Gauderman J (2004) Quanto, accessed at http://hydra.usc.edu/ GxE/
73. Tracey KJ, Warren HS (2004) Human genetics: an inflammatory issue. Nature 429:35-37
74. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA (2004) Mapping complex disease loci in whole-genome association studies. Nature 429:446-452
75. Crawford DC, Carlson CS, Rieder MJ, Carrington DP, Yi Q, Smith JD, Eberle MA, Kruglyak L, Nickerson DA (2004) Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations. Am J Hum Genet 74:610-622
76. Crawford DC, Nickerson DA (2005) Definition and clinical importance of haplotypes. Annu Rev Med 56:303-320
77. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125:279-284
78. Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155:945-959
79. Kohler K, Bickeboller H (2006) Case-control association tests correcting for population stratification. Ann Hum Genet 70:98-115
80. Devlin B, Roeder K, Wasserman L (2001) Genomic control, a new approach to genetic-based association studies. Theor Popul Biol 60:155-166
81. Bacanu SA, Devlin B, Roeder K (2000) The power of genomic control. Am J Hum Genet 66:1933-1944
82. Gong MN, Thompson BT, Williams PL, Zhou W, Wang MZ, Pothier L, Christiani DC (2006) Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome. Eur Respir J 27:674-681